Use six gates. A low price must not compensate for an unresolved route or quality concern.
| Gate | Question to answer | Recommended owner | Evidence required to advance |
|---|---|---|---|
| 1. Define | Are we buying stock, appointing a dispenser or facilitating patient access? | COO and finance | Route diagram, payer map and decision scope |
| 2. Qualify | Is the exact proposed arrangement supportable? | Medical director and counsel | Product-, facility-, state- and use-specific assessment |
| 3. Verify | Can the partner support our patients and operating requirements? | Procurement and pharmacy/quality lead | Dated evidence register and coverage matrix |
| 4. Compare | What does each equivalent scenario cost, and who pays? | CFO and procurement | Matched quotations and a transparent cost workbook |
| 5. Protect | Can we manage failures, changes and an eventual exit? | Counsel, operations and security | Negotiated obligations and transition responsibilities |
| 6. Prove | Does the workflow work through dispensing and refill? | Operations and clinical leadership | Controlled pilot, exception log and go/no-go decision |
If access is already failing, run continuity work in parallel. Assign an incident owner, identify affected prescriptions in the clinical system, contact the dispensing partner and escalate treatment questions to clinicians. Do not wait for a complete competitive procurement exercise—but do not treat urgency as permission to bypass the route and quality gates.
Explore the table row by row
A working view of the research
1. Define
- Question to answer
- Are we buying stock, appointing a dispenser or facilitating patient access?
- Recommended owner
- COO and finance
- Evidence required to advance
- Route diagram, payer map and decision scope
Sources cited on this page
See the section’s source register for the research context.
Section sources →